PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 180 filers reported holding PTC THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $424 | -42.2% | 18,941 | +5.1% | 0.00% | -40.0% |
| Q2 2023 | $733 | -24.0% | 18,019 | -9.6% | 0.01% | -16.7% |
| Q1 2023 | $965 | +29.5% | 19,930 | +2.0% | 0.01% | +20.0% |
| Q4 2022 | $745 | -99.9% | 19,530 | -7.2% | 0.01% | -37.5% |
| Q3 2022 | $1,056,000 | +158.8% | 21,043 | +106.8% | 0.01% | +166.7% |
| Q2 2022 | $408,000 | -16.0% | 10,177 | -21.9% | 0.00% | +50.0% |
| Q1 2022 | $486,000 | -0.2% | 13,027 | +6.4% | 0.00% | 0.0% |
| Q4 2021 | $487,000 | +28.2% | 12,238 | +20.0% | 0.00% | 0.0% |
| Q3 2021 | $380,000 | +10.1% | 10,200 | +25.2% | 0.00% | 0.0% |
| Q2 2021 | $345,000 | +4.9% | 8,150 | +17.3% | 0.00% | 0.0% |
| Q1 2021 | $329,000 | -5.5% | 6,948 | +21.9% | 0.00% | 0.0% |
| Q4 2020 | $348,000 | -93.5% | 5,702 | -95.2% | 0.00% | -95.6% |
| Q2 2019 | $5,379,000 | -5.9% | 119,528 | -21.3% | 0.04% | -8.2% |
| Q1 2019 | $5,714,000 | +2521.1% | 151,805 | +3166.0% | 0.05% | +2350.0% |
| Q3 2018 | $218,000 | -9.9% | 4,648 | -35.1% | 0.00% | 0.0% |
| Q2 2018 | $242,000 | +2.5% | 7,165 | -17.9% | 0.00% | 0.0% |
| Q1 2018 | $236,000 | +3.5% | 8,723 | -36.1% | 0.00% | 0.0% |
| Q4 2017 | $228,000 | +660.0% | 13,647 | +221.1% | 0.00% | – |
| Q2 2016 | $30,000 | +30.4% | 4,250 | +17.4% | 0.00% | – |
| Q1 2016 | $23,000 | -73.6% | 3,621 | +35.6% | 0.00% | -100.0% |
| Q4 2015 | $87,000 | -7.4% | 2,670 | -24.3% | 0.00% | 0.0% |
| Q3 2015 | $94,000 | +74.1% | 3,527 | +211.8% | 0.00% | – |
| Q2 2015 | $54,000 | +35.0% | 1,131 | +70.8% | 0.00% | – |
| Q1 2015 | $40,000 | +21.2% | 662 | +5.2% | 0.00% | – |
| Q4 2014 | $33,000 | +17.9% | 629 | -2.2% | 0.00% | – |
| Q3 2014 | $28,000 | +55.6% | 643 | -7.3% | 0.00% | – |
| Q2 2014 | $18,000 | 0.0% | 694 | 0.0% | 0.00% | – |
| Q1 2014 | $18,000 | +200.0% | 694 | +87.1% | 0.00% | – |
| Q4 2013 | $6,000 | – | 371 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayer Capital Management, LP | 416,666 | $7,153,000 | 38.92% |
| Novo Holdings A/S | 747,359 | $11,210,000 | 2.78% |
| Bain Capital Public Equity Management, LLC | 2,333,333 | $50,073,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,027 | $18,134,000 | 0.84% |
| HealthCor Management, L.P. | 732,200 | $15,713,000 | 0.84% |
| RA Capital Management | 300,000 | $6,438,000 | 0.67% |
| Catalyst Capital Advisors LLC | 30,666 | $658,000 | 0.36% |
| CR Intrinsic Investors, LLC | 119,237 | $2,559,000 | 0.08% |
| Weiss Multi-Strategy Advisers LLC | 284,130 | $6,098,000 | 0.07% |
| SECTORAL ASSET MANAGEMENT INC | 57,519 | $1,234,000 | 0.06% |